Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
4 participants
OBSERVATIONAL
2020-01-15
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Exposure Therapy for the Treatment of Social Phobia
NCT02379949
Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth
NCT03135990
Treatment of Social Anxiety in Youth
NCT02443051
Augmentation Study of A Computerized Treatment for Social Anxiety Disorder
NCT02372019
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
NCT04850989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Despite the importance of avoidance, however, it is very difficult to assess a patient's tendency to avoid. Many prior assessments of avoidance measure adaptive (i.e., helpful) avoidance, in which an individual learns to avoid a truly noxious stimulus. However, anxiety disorders are characterized by maladaptive avoidance, in which a relatively safe stimulus is avoided resulting in interference with the individual's goals. In this study, the first aim is to validate a virtual reality paradigm to measure maladaptive avoidance behavior in adults with social anxiety disorder. The second aim is to test whether maladaptive avoidance behavior relates to safety learning (measured by a fear extinction task).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Social Anxiety Disorder
A group of adults with social anxiety disorder will be recruited for a psychological/behavioral research study.
No intervention
There will be no intervention in this study. Adults with social anxiety disorder will complete research assessments related to fear and safety learning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
There will be no intervention in this study. Adults with social anxiety disorder will complete research assessments related to fear and safety learning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primary diagnosis of social anxiety disorder
* fluent spoken and written English
* able to provide informed consent
Exclusion Criteria
* moderate or severe substance use disorder in the past 12 months
* current major depressive episode greater than moderate severity (PHQ-9 score \>14)
* high risk for suicide (\>8 on the MINI Suicidality section and/or clinician judgment that immediate medical attention is necessary)
* general medical condition or impediment to vision, hearing, or motor function likely to interfere with assessments
* benzodiazepine use in the past 2 weeks
* cannabis use for anxiety management in the past 2 weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tali Manber Ball, PhD
Instructor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-48367
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.